0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of Archives of Internal Medicine |

In This Issue of Archives of Internal Medicine FREE

Arch Intern Med. 2005;165(16):1812. doi:10.1001/archinte.165.16.1812.
Text Size: A A A
Published online

READY FOR GENOMIC MEDICINE?

Recent developments in the field of human genomics have led to varying predictions regarding the potential for genomic medicine to transform clinical practice. Whether health care systems are ready to establish the infrastructure and expertise necessary to derive full value from genomic and molecular medicine remains uncertain. In this study, Billings and colleagues examined the readiness of health care systems to incorporate genomic medicine, based on extensive interviews involving senior staff members and executives of relevant public and private organizations. Their results suggest that knowledge of genomic medicine, as well as investment in infrastructure with which it is associated, is limited among leading health care decision makers.

See Article

ATYPICAL ANTIPSYCHOTICS AND PARKINSONISM

The newer atypical antipsychotic agents are thought to be less likely to produce parkinsonism compared with the older typical antipsychotic therapy, although this has not been well documented. In a retrospective cohort study of more than 25 000 older adults, the results of this study by Rochon and colleagues demonstrate that when the potency and dose of the antipsychotic therapies are considered, atypical antipsychotic therapies are not necessarily safer than typical antipsychotic therapy in relation to the development of parkinsonism. These findings suggest that caution should be used particularly when prescribing high-dose atypical antipsychotic therapy

See Article

INDIVIDUALIZED SCREENING INTERVAL FOR PROSTATE CANCER BASED ON PROSTATE-SPECIFIC ANTIGEN LEVEL

Based on data from a population-based, prospective, randomized prostate cancer screening trial, this study by Aus and colleagues examined the cumulative risk of being diagnosed as having prostate cancer in relation to the individual baseline serum prostate-specific antigen level. The results show that it is fully possible to individualize the retesting interval for prostate-specific antigen based on the baseline prostate-specific antigen level without affecting the prostate cancer detection rate.

See Article

DIFFERENCES IN SCREENING MAMMOGRAPHY OUTCOMES AMONG WHITE, CHINESE, AND FILIPINO WOMEN

The absolute benefit of screening mammography varies according to the age-specific accuracy and efficacy of mammography as well as the incidence of breast cancer in the population screened. Asian women have lower breast cancer incidence and mortality rates compared with white women. Screening mammography outcomes among Asian women in the United States have received little attention. This study found that screening mammography has similar accuracy among white, Chinese, and Filipino women despite lower rates of invasive cancer in Asian women. The rate of ductal carcinoma in situ was similar in all ethnic groups. These results suggest that the absolute benefit of screening, in terms of breast cancer deaths averted, is likely to be less among Asian women, and overdiagnosis of ductal carcinoma in situ with screening mammography among Asian women is likely to be comparable to that of white women.

See Article

GENETIC LIABILITY TO FRACTURES IN THE ELDERLY

Although there is a strong genetic influence on the variation in bone density, the genetic impact on the causation of osteoporotic fractures is unclear. A large Swedish nationwide twin study enabled Michaëlsson and colleagues to investigate the genetic and environmental influence at various ages on fracture occurrence after the age of 50 years in elderly men and women. Genetic variation in liability to fracture differed considerably by type of fracture and age. Only a modest age-adjusted overall fracture variance was explained by genetic variation. A greater genetic influence was observed for osteoporotic fractures, especially hip fractures. The heritability of hip fractures was estimated to average 50% and was even greater for hip fractures before the age of 70 years but was negligible after the approximate median age, 80 years. These results suggest that the search for susceptibility genes and environmental factors that may modulate expression of these genes in young-old patients with hip fracture, the most devastating osteoporotic fracture, should be encouraged. Prevention of fractures in the oldest-old should be focused on lifestyle interventions.

Place holder to copy figure label and caption

The age-adjusted estimated heritability (black bars), shared environmental influence (gray bars), and nonshared environmental influence (white bars) of all fractures by age at first fracture within each twin pair.

Graphic Jump Location

See Article

Figures

Place holder to copy figure label and caption

The age-adjusted estimated heritability (black bars), shared environmental influence (gray bars), and nonshared environmental influence (white bars) of all fractures by age at first fracture within each twin pair.

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...